Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics

Journal of Medicinal Chemistry

Volumn 46, Issue 7, 2003, Pages 1204-1209

  Printsevskaya, Svetlana S ^a   Pavlov, Andrey Y ^a   Olsufyeva, Evgenia N ^a   Mirchink, Elena P ^a   Preobrazhenskaya, Maria N ^a  

^a GAUSE INSTITUTE OF NEW ANTIBIOTICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; ANTIBIOTIC AGENT; DEXTRO ALANINE; EREMOMYCIN; EREMOMYCIN AGLYCON; GLYCOPEPTIDE; NOR DEXTRO LEUCYLEREMOMYCIN; NOR DEXTRO LEUCYLEREMOMYCIN AGLYCON; PENTAPEPTIDE; PEPTIDOGLYCAN; TEICOPLANIN; TEICOPLANIN AGLYCON; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; DRUG MECHANISM; DRUG RESISTANCE; DRUG SENSITIVITY; ENTEROCOCCUS; MINIMUM INHIBITORY CONCENTRATION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GLYCOPEPTIDES; GRAM-POSITIVE BACTERIA; HYDROPHOBICITY; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STRUCTURE-ACTIVITY RELATIONSHIP; TEICOPLANIN; VANCOMYCIN;

EID: 0037468882     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm020320o     Document Type: Article

References (21)

1. Malabarba, A.; Nicas, T. I.; Thompson, R. S. Structural Modifications of Glycopeptide Antibiotics. Med. Res. Rev. 1997, 17, 69-137.
2. Ge, M.; Chen, Zh.; Onishi, H. R.; Kohler, J.; Silver, L. L.; Kerns, R.; Fukuzawa, S.; Thompson, C.; Kahne, D. Vancomycin Derivatives That Inhibit Peptidoglycan Synthesis Without Binding D-Ala-D-Ala. Science 1999, 284, 507-511.
3. Pavlov, A. Y.; Preobrazhenskaya, M. N. Chemical Modification of Glycopeptide Antibiotics. Russ. J. Bioorg. Chem. 1998, 24, 570-587.
4. Olsufyeva, E. N.; Berdnikova, T. F.; Miroshnikova, O. V.; Reznikova, M. I.; Preobrazhenskaya, M. N. Chemical Modification of Antibiotic Eremomycin at the Asparagin Side Chain. J. Antibiot. 1999, 52, 319-324.
5. Miroshnikova, O. V.; Printsevskaya, S. S.; Olsufyeva, E. N.; Pavlov, A. Y.; Nilius, A.; Hensey-Rudloff, D.; Preobrazhenskaya, M. N. Structure-Activity Relationships in the Series of Eremomycin Carboxamides. J. Antibiot. 2000, 53, 286-293.
6. Cooper, R. D. G.; Snyder, N. J.; Zweifel, M. J.; Staszak, M. A.; Rodrigues, M. J.; Huff, B. E.; Thompson, R. C. Reductive Alkylation of Glycopeptide Antibiotics: Synthesis and Antibacterial Activity. J Antibiot. 1996, 49, 575-581.
7. Nicas, T. I.; Mullen, D. L.; Flokowitsch, J. E.; Preston, D. A.; Snyder, N. J.; Zweifel, M. J.; Wilkie, S. C.; Rodriguez, M. J.; Thompson, R. C.; Cooper R. D. G. Semisynthetic glycopeptide antibiotics derived LY264826 active against vancomycin resistant enterococci. Antimicrob. Agents Chemother. 1996, 40, 2194-2199.
8. Printsevskaya, S. S.; Pavlov, A. Y.; Olsufyeva, E. N.; Mirchink, E. P.; Isakova, E. B.; Reznikova, M. I.; Goldman, R. C.; Branstrom, A. A.; Baizman, E. R.; Longley, C. B.; Sztaricskai, F.; Batta, G.; Preobrazhenskaya, M. N. Synthesis and Mode of Action of Hydrophobic Derivatives of the Glycopeptide Antibiotic Eremomycin and des-(N-methyl-D-leucyl)eremomycin Against Glycopeptide-Sensitive and Resistant Bacteria. J. Med. Chem. 2002, 45, 1340-1347.
9. Roy, R. S.; Yang, P.; Kodali, S.; Xiong, Y.; Kim, R. M.; Griffin, P. R.; Onishi, R.; Kohler, J.; Silver, L. L.; Chapman, K. Direct Interaction of a Vancomycin Derivative with Bacterial Enzymes Involved in Cell Wall Biosynthesis. Chem. Biol. 2001, 8, 1095-1106.
10. Goldman, R. C.; Baizman, E. R.; Longley, C. B.; Branstrom, A. A. Chlorobiphenyl-Desleucyl-Vancomycin Inhibits the Transglycosylase Required for Peptidoglycan Synthesis in Bacteria. FEMS Microb. Lett. 2000, 183, 209-214.
11. Eggert, U. S.; Ruiz, N.; Falcone, B. V.; Branstrom, A. A.; Goldman, R. C.; Silhavy, T. J.; Kahne, D. Genetic Basis for Activity Differences Between Vancomycin and Glycolipid Derivatives of Vancomycin. Science 2001, 294, 361-366.
12. Sun, B.; Chen, Z.; Eggert, U. S.; Shaw, S. J.; LaTour J. V.; Kahne, D. Hybrid Glycopeptide Antibiotics. J. Am. Chem. Soc. 2001, 123, 12722-12723.
13. Allen, N. E.; LeTourneau, D. L.; Hobbs, J. N. The Role of Hydrophobic Side Chains as Determinants of Antibacterial Activity of Semisynthetic Glycopeptide Antibiotics. J. Antibiot. 1997, 50, 677-684.
14. Berdnikova, T. F.; Lomakina, N. N.; Olsufyeva, E. N.; Alexandrova, L. G.; Potapova, N. P.; Rozinov, B. V.; Malkova, I. V.; Orlova, G. I. Structure and Antimicrobial Activity of Products of Partial Degradation of Antibiotic Eremomycin. Antibiot. Chemother. (Russ.) 1991, 36, 28-31.
15. Miroshnikova, O. V.; Berdnikova, T. F.; Olsufyeva, E. N.; Pavlov, A. Y.; Reznikova, M. I.; Preobrazhenskaya, M. N.; Ciabatti, R.; Malabarba, A.; Colombo, L. A Modification of the N-Terminal Amino Acid in the Eremomycin Aglycone. J. Antibiot. 1996, 49, 1157-1161.
16. Malabarba, A.; Ciabatti, R.; Kettenring, J.; Ferrari, P.; Vekey, K.; Bellasio, E.; Denaro, M. Structural Modifications of the Active Site in Teicoplanin and Related Glycopeptides. 1. Reductive Hydrolysis of the 1,2- and 2,3-Peptide Bonds. J. Org. Chem. 1996, 61, 2137-2150.
17. Malabarba, A.; Ciabatti, R.; Maggini, M.; Ferrari, P.; Vekey, K.; Colombo, L.; Denaro, M. Structural Modifications of the Active Site in Teicoplanin and Related Glycopeptides. 2. Deglucoteicoplanin-Derived Tetrapeptide. J. Org. Chem. 1996, 61, 2151-2157.
18. Kaplan, J.; Korty B. D.; Axelsen P. H.; Loll, P. J. The Role of Sugar Residues in Molecular Recognition by Vancomycin. J. Med. Chem. 2001, 44, 1837-1840.
19. Printsevskaya, S. S.; Olsufeva, E. N.; Lazhko, E. I.; Preobrazhenskaya, M. N. Antibiotic N′N″-Dibenzyleremomycin with Reduced 1,2-Peptide Bond. Russ. J. Bioorg. Chem. 2002, 28, 65-73.
20. Chen, Z.; Eggert, U. S.; Shaw, S. S.; Sun, B.; LaTour, J. V.; Kahne, D. Tetrahedron 2002, 58, 6585-6594.
21. Pavlov, A. Y.; Preobrazhenskaya, M. N.; Malabarba, A.; Ciabatti, R.; Colombo, L. Mono and Double Modified Teicoplanin Aglycon Derivatives on the Amino Acid No. 7; Structure-Activity Relationship. J. Antibiot. 1998, 51, 73-81.